Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim Licenses DoubleTwist s CAT

NEW YORK, June 20- Boehringer Ingelheim has signed a multi-site license for DoubleTwist’s Clustering and Alignment Tools (CAT), the companies announced Wednesday.

DoubleTwist declined to reveal the financial details of the agreement.

"We chose CAT not only for the quality of the technology, but also because we feel that DoubleTwist as a global company is best positioned to support the discovery efforts of our global research units," Bernd Wetzel, head of corporate division research and nonclinical development at Boehringer Ingelheim, said in a statement.

CAT organizes expressed sequence tags and mRNA sequences into full-length gene sequences, uses statistics to correct sequencing and cloning errors, and isolates and analyzes alternative splice forms.

Currently, over 30 companies subscribe to CAT, including Millenium Pharmaceuticals, Affymetrix, and Bristol-Myers Squibb, Oakland-based DoubleTwist said.   

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.